Highlights Broad Clinical Benefits of AC5® Technology and Use in Managing Biofilm Infected Wounds FRAMINGHAM, Mass., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical devices, presented at the Symposium on Advanced Wound… Read More..

-- Paid Subscribers as of September 30, 2021 Increased to Over 1,256,000**, a Net Increase of Over 320,000 a Year Ago - Monthly Average Revenue Per User Was $3.41** vs. $3.38 in Q1 Fiscal 2022 -- During Fiscal 2022, LiveOne Has Added Over 170,000 Paid Members Into Its New Expanded Membership Program --… Read More..

Company Placing Renewed Emphasis on the Country’s ‘Stroke Belt’, Increasing its Commitment to Address the Growing Needs of Stroke Patients TORONTO & BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges… Read More..